COMPANY
Agendia
FDA-cleared device company Past trials only
Timeline
- Trial start —: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles source ↗
- Trial start —: Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry source ↗
- Trial start —: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score source ↗
- Trial start —: The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients source ↗
- Trial start Phase 4: MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I source ↗
- Trial start —: NBRST: Prospective Neo-adjuvant REGISTRY Trial source ↗
- Trial start —: A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint source ↗
- Trial start —: Validation of 70-gene MammaPrint Profile in Japanese Population source ↗
Upcoming milestones
- 2037-04 (ESTIMATED) · · MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles · NCT03053193
Clinical trials (lead sponsor) 8
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03053193 | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles | Not listed | Recruiting | Apr 28, 2017 | 2037-04 (estimated) |
| NCT01479101 | NBRST: Prospective Neo-adjuvant REGISTRY Trial | Not listed | Completed | 2011-07 | 2015-01 (actual) |
| NCT02669745 | The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients | Not listed | Completed | 2012-01 | 2019-05 (actual) |
| NCT00903565 | A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint | Not listed | Unknown status (ClinicalTrials.gov) | 2008-09 | 2019-12 (estimated) |
| NCT01501487 | MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I | Phase 4 | Completed | 2011-10 | 2016-02 (actual) |
| NCT02670577 | Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry | Not listed | Completed | 2015-11 | Apr 30, 2017 (actual) |
| NCT01617954 | PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score | Not listed | Completed | 2012-05 | 2015-12 (actual) |
| NCT00904566 | Validation of 70-gene MammaPrint Profile in Japanese Population | Not listed | Completed | 2008-04 | 2009-01 (actual) |